The remaining 37 control subjects, 32 MCIs and 117 patients with Alzheimer's disease were different in sex distribution, apolipoprotein E (ApoE) ε4 carriers, age, and general intelligence (Table 1), thus, in further analyses, data were controlled for age, ApoE ε4, and gender. This evidence concerns the gene APOE and Alzheimer disease.